Xemetil MD 5 Tablet contains Prochlorperazine 5 mg, a phenothiazine derivative primarily used as an antiemetic and antipsychotic agent. It is indicated for the management of nausea and vomiting associated with various conditions, including migraine, chemotherapy, radiation therapy, and postoperative states. Prochlorperazine acts by blocking dopamine D2 receptors in the chemoreceptor trigger zone of the central nervous system, thereby inhibiting the vomiting reflex. Additionally, it exhibits mild antipsychotic properties through dopamine antagonism, making it useful in controlling symptoms of schizophrenia and anxiety-related psychoses. Xemetil MD 5 Tablet should be administered as per the prescribing physician’s instructions, with dosage tailored to the severity of symptoms and patient response. Caution is advised in patients with a history of hypersensitivity to phenothiazines, Parkinson’s disease, cardiovascular disorders, or hepatic impairment. Common adverse effects include sedation, dizziness, extrapyramidal symptoms, dry mouth, and hypotension. Patients should avoid alcohol and activities requiring mental alertness while on therapy. Prochlorperazine is contraindicated in comatose states, severe CNS depression, and bone marrow suppression. Regular monitoring is recommended during prolonged use to detect potential side effects. Xemetil MD 5 Tablet offers effective symptomatic relief from nausea and vomiting, improving patient comfort and quality of life.